TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Alcohol Urge Questionnaire (AUQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: State-Trait Anxiety Inventory (STAI-6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUClast of INC280
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of INC280
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of INC280
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of central diabetes insipidus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lack of central diabetes insipidus development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Western Ontario Mac Master Questionnaire (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Visual Analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Event Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Event Rate for a Composite of Incident Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: simplified verbal scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fibromyalgia Impact Questionnaire (FIQR) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of MMR or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Weighted Sum of Pain Intensity Differences (SPID) in Sore Throat Pain Intensity Scale (STPIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: optimal dosing of the vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: in vivo peptide-specific immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: smoking quit rate change from baseline at 3-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: smoking quit rate change from baseline at 6-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stool characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in ejection fraction after 36 training sessions (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes of the maximum heart rate in a effort test after 36 training sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in the levels of Quality of life after 36 training sessions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Relief of paradoxical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rheumatoid arthritis Disease Activity Score (DAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune Disease Control Rate (iDCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Composite of Adjudicated Total Venous Thromboembolism (VTE) and VTE-related Death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of Major Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Clinically Relevant Non-Major (CRNM) Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of glucose intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Description of the lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Missed Medication Doses - Past 30 Days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Missed Medication-related Visits - Past 30 Days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrence post-ablation
Endpoint domain: Mortality/survival
Primary endpoint: Geometric Mean Fold Rise (GMFR) for Serotype-Specific Pneumococcal IgG Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional outcome through the Olerud-Moland score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to Radiographic Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal Fluid HIV RNA Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pediatric Anesthesia Emergence Delirium Scale (PAED) ≥ 10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inflammatory response (IL-6 level)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse Effect
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Effect
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of serum s100β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of serum NSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of serum GFAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of per cent of plaque burden from baseline to follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with major adverse cardiac events related to plaque burden
Endpoint domain: Adverse events/effects
Primary endpoint: Bone volume fraction (BV/TV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overdiagnosis of thyroid cancer
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in standardized scores on a neuropsychological test battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite health risk behavior score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life as measured by DEMQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life as measured by DEMQOL proxy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Participants With Antibody Titer ≥40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of ancients undergoing R0 resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PLL length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative assessment of the cause of the renal stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Risk profile for recurrence of renal stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Immediate change in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of pain change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers of frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hospitalisation due to febrile neutropenia and/or infection
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatitis B Surface Antibody Seroprotective Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under the Concentration Curve (AUC(0-t Last))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Maximum Observed Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Intra-procedural complications
Endpoint domain: Adverse events/effects
Primary endpoint: Procedure technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Expression of mRNA and DNA markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mRNA and DNA markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analysis of MpMRIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Cobb Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-Xa Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary fatty acid partitioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease of inflammation in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Rodnan Skin Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency of COPD acute exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Sexual Dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Depression Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With a Significant Arrhythmia Detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urine analysis results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: change of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Fibrosis Staging Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood androstenedione and testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of patients correctly classified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Decrease of cortical thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants With Disease Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-related mortality (TRM) after PBSC infusion
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of treatment-related mortality (TRM) after DLI
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients who successfully achieve mixed chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of biomarkers of Exposure (BoExp) to HPHCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of CVD-related biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Connor-Davidson resilience scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: complications after nipple sparing mastectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Length of scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success rate of IVCF implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With In Vivo Expansion of Infused Allogeneic NK Cell Product
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in erythrocyte sedimentation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal pain/discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable Bowel Syndrome degree-of-relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proportion of heavy drinking days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Hopkins Verbal Learning Test (HVLT) Total Recall Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Delayed Recall Cognitive Domain Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Executive Function Cognitive Domain Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Positive and Negative Syndrome Scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in MATRICS Consensus Cognitive Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of chromosomal aneuploidy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With New HIV Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients recruited into the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients who adhere to trial protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Helicobacter pylori status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Treatment success rate in IGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported parental successful smoking reduction rate at week-24
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of handover of trauma patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handover of neck of femur (NOF) fracture patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handover of unwell patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Berg Balance Scale (BBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy against depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy against anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in GSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Emax,IPA,0-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous preterm birth prior to 35 weeks gestation
Endpoint domain: Mortality/survival
Primary endpoint: 12-Month Progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Total anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Whole Skeleton Skeletal Plasma Clearance of 99m Tc-MDP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in antibiotic prescribing for upper respiratory infections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in prescribing of antipsychotics for dementia symptoms
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Vitamin D laboratory testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in PSA ordering (annual screening)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Profile of Mood Scale Total Negative Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Marijuana Withdrawal Questionnaire (MWC) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: POMS Vigor/Positive Affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Mean Diurnal Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale score for Dentinal Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death after acute myocardial infarction or heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction with motor rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visceral Fat Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of Hot Flashes (Vasomotor Symptom Frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Immunological Response to Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improved knowledge about prostate cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction with education and screening model
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Required a Blood Transfusion During Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency distribution and severity of steatosis stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Frequency distribution and severity of liver fibrosis stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change in Mean Serum High Density Lipoprotein Cholesterol Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: feasibility of neoadjuvant pembrolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOXP3 regulatory T cell levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sexual behavior changes
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prevention or delay of major depressive episodes
Endpoint domain: Mortality/survival
Primary endpoint: Prevention or delay of non-affective disorder episodes
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Mean Seated Systolic BP (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: painful stimulus perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HR measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Motor and Process Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Community Participation Index
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ICU-Free Days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Resting state functional MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Left ventricle end-systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: intervention rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With TEAEs Due to Laboratory, Electrocardiogram, and Vital Sign Findings
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Moist Desquamation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Potentially Clinically Significant Abnormalities (PCSA)
Endpoint domain: Adverse events/effects
Primary endpoint: Oral Glucose Tolerance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intra-individual difference in TAFO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of Hand-Foot Skin Reaction (HFSR)
Endpoint domain: Adverse events/effects
Primary endpoint: Vertigo-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative incidence of ESRD requiring dialysis or transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Rate of decline of GFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Mean Systolic Blood Pressure (MSSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma Zinc changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social Connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Assessment of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change of maximum Visual Analogue Scale (VAS) score for pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of blind intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of Total IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol use scale-revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug use scale-revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes